Vertex Pharmaceuticals

YTD

ALL

Trade Vertex Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.

CEO

Reshma Kewalramani

CEOReshma Kewalramani

Employees

6,400

Employees6,400

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

1989

Founded1989

Employees

6,400

Employees6,400

VRTX Key Statistics

Market cap

115.05B

Market cap115.05B

Price-Earnings ratio

29.69

Price-Earnings ratio29.69

Dividend yield

—

Dividend yield—

Average volume

1.42M

Average volume1.42M

High today

$455.35

High today$455.35

Low today

$449.32

Low today$449.32

Open price

$451.23

Open price$451.23

Volume

77.31K

Volume77.31K

52 Week high

$510.77

52 Week high$510.77

52 Week low

$362.50

52 Week low$362.50

Stock Snapshot

Vertex Pharmaceuticals(VRTX) stock is priced at $452.91, giving the company a market capitalization of 115.05B. It carries a P/E multiple of 29.69.

During the trading session on 2026-03-26, Vertex Pharmaceuticals(VRTX) shares reached a daily high of $455.35 and a low of $449.32. At a current price of $452.91, the stock is +0.8% higher than the low and still -0.5% under the high.

Trading volume for Vertex Pharmaceuticals(VRTX) stock has reached 77.31K, versus its average volume of 1.42M.

Over the past 52 weeks, Vertex Pharmaceuticals(VRTX) stock has traded between a high of $510.77 and a low of $362.50.

VRTX News

Nasdaq 18h

Where Will Vertex Pharmaceuticals Be in 1 Year?

Key Points Vertex Pharmaceuticals most important business should still drive sales growth in the 12 months. The biotech could have an improved lineup by next...

Investor's Business Daily 1d

Why Maze Therapeutics Plunged 20%-Plus Despite 'Overwhelming Positive' Data

Vertex Pharmaceuticals Joins Elite List Of Stocks With 95-Plus Composite Rating 3/10/2026 Vertex Pharmaceuticals saw an improvement in its IBD SmartSelect Comp...

Simply Wall St 3d

A Look At Vertex Pharmaceuticals Valuation After Recent Share Price Pullback

Advertisement Vertex Pharmaceuticals stock moves after recent trading performance Vertex Pharmaceuticals (VRTX) has drawn attention after recent trading, with...

Analyst ratings

78%

of 36 ratings

Buy

77.8%

Hold

16.7%

Sell

5.6%

More VRTX News

Nasdaq 6d

Vertex Stock Falls 4.8% in a Month: Buying Opportunity or Red Flag?

Vertex Pharmaceuticals Incorporated VRTX stock has declined 4.8% over the past month. This reflects concerns over the commercial potential of its new drugs, Jou...

People also own

Based on the portfolios of people who own VRTX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.